Shmerling, MD Senior Faculty Editor, Harvard Health Publishing
Sustainable, gradual weight loss Nooms microdosing program reports patients losing up to 11 pounds in 30 days and 17 pounds in 60 days
Injectable GHK-Cu in humans has a much thinner evidence base
L929 or HEK293T cells (negative controls) at cell densities of 5 10 4 , 1 10 5 and 2 10 5 cells/well were then seeded into wells containing NP cells and were stimulated with or without 1 gmL 1 lipopolysaccharide (LPS) for 24 h
In a functional medicine practice, a clinician might consider a conversation about GHK Cu if someone: Is already addressing foundational longevity drivers (sleep, strength training, protein, glucose regulation) Has skin or connective tissue goals and wants evidence informed support Is in a repair phase after a period of high stress, illness, or inflammatory burden, and foundations are stable Wants a careful, monitored approach rather than internet protocols And we would still want to ask: What is your mineral status and overall nutrition status
Though the panels decision is a green flag for the peptide industry, there remain a number of regulatory steps before the peptides it approved can be taken to market for legal human consumption